Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
Cancer Research
|
March 19, 2011
Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
Yuanmei Lou, Paul C McDonald, Arusha Oloumi, et al.
The New England Journal of Medicine
|
December 12, 2019
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Dennis J Slamon, Patrick Neven, Stephen Chia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2018
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3
Dennis J Slamon, Patrick Neven, Stephen Chia, et al.
Breast Cancer Research and Treatment
|
April 11, 2020
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy
Karin Ribi, Weixiu Luo, Barbara A Walley, et al.
Nature Communications
|
August 4, 2022
Accurate determination of CRISPR-mediated gene fitness in transplantable tumours
Peter Eirew, Ciara O'Flanagan, Jerome Ting, et al.
The Lancet. Oncology
|
June 4, 2017
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
José Baselga, Seock-Ah Im, Hiroji Iwata, et al.
JAMA Oncology
|
April 12, 2019
Current Landscape of Immunotherapy in Breast Cancer: A Review
Sylvia Adams, Margaret E Gatti-Mays, Kevin Kalinsky, et al.
The New England Journal of Medicine
|
June 2, 2025
First-Line Camizestrant for Emerging <i>ESR1</i>-Mutated Advanced Breast Cancer
François-Clément Bidard, Erica L Mayer, Yeon Hee Park, et al.
The Oncologist
|
April 25, 2015
Defining breast cancer intrinsic subtypes by quantitative receptor expression
Maggie C U Cheang, Miguel Martin, Torsten O Nielsen, et al.
Nature
|
August 26, 2021
Genome of a middle Holocene hunter-gatherer from Wallacea
Selina Carlhoff, Akin Duli, Kathrin Nägele, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
Cancer Research
|
March 19, 2011
Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
Yuanmei Lou, Paul C McDonald, Arusha Oloumi, et al.
The New England Journal of Medicine
|
December 12, 2019
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Dennis J Slamon, Patrick Neven, Stephen Chia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2018
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3
Dennis J Slamon, Patrick Neven, Stephen Chia, et al.
Breast Cancer Research and Treatment
|
April 11, 2020
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy
Karin Ribi, Weixiu Luo, Barbara A Walley, et al.
Nature Communications
|
August 4, 2022
Accurate determination of CRISPR-mediated gene fitness in transplantable tumours
Peter Eirew, Ciara O'Flanagan, Jerome Ting, et al.
The Lancet. Oncology
|
June 4, 2017
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
José Baselga, Seock-Ah Im, Hiroji Iwata, et al.
JAMA Oncology
|
April 12, 2019
Current Landscape of Immunotherapy in Breast Cancer: A Review
Sylvia Adams, Margaret E Gatti-Mays, Kevin Kalinsky, et al.
The New England Journal of Medicine
|
June 2, 2025
First-Line Camizestrant for Emerging <i>ESR1</i>-Mutated Advanced Breast Cancer
François-Clément Bidard, Erica L Mayer, Yeon Hee Park, et al.
The Oncologist
|
April 25, 2015
Defining breast cancer intrinsic subtypes by quantitative receptor expression
Maggie C U Cheang, Miguel Martin, Torsten O Nielsen, et al.
Nature
|
August 26, 2021
Genome of a middle Holocene hunter-gatherer from Wallacea
Selina Carlhoff, Akin Duli, Kathrin Nägele, et al.
Page
of 11